Cost Plus Drugs BBB and Consumer-Complaint Trends

Is Cost Plus Drugs Legit?

Cost Plus Drugs is a legitimate, state-licensed, prescription-requiring online pharmacy. It holds a Texas State Board of Pharmacy permit, requires a valid prescription for every Rx product, and has earned LegitScript certification, the same independent verification standard used by Google and Bing to approve pharmacy advertisers. No FDA warning letters had been issued to Cost Plus Drugs as of January 2025.

What LegitScript Certification Actually Means

LegitScript reviews pharmacies against standards drawn partly from the FDA's BeSafeRx campaign guidance and the federal Ryan Haight Online Pharmacy Consumer Protection Act. A certified pharmacy must require valid prescriptions, be licensed in every state where it dispenses, and disclose its physical address. Cost Plus Drugs meets all three criteria.

The FDA maintains a list of operations that have received warning letters for unlicensed internet pharmacy activity. That public database does not include Cost Plus Drugs as of the date of this review.

State Pharmacy Board Standing

The Texas State Board of Pharmacy licenses and inspects Cost Plus Drugs' dispensing operation. State board disciplinary actions are public record. A search of the board's online license-verification portal in January 2025 returned no active disciplinary orders against the pharmacy permit.

Other states may require separate non-resident pharmacy permits for shipments into their jurisdiction. Patients should confirm their state's rules through their own state board of pharmacy, which the National Association of Boards of Pharmacy (NABP) lists centrally.

BBB Profile and Complaint Volume

Cost Plus Drugs is not BBB-accredited as of January 2025. A BBB profile exists and is publicly searchable, but the company has not paid for or pursued formal accreditation. That distinction matters: accreditation is a paid membership, not a government or regulatory certification. The absence of accreditation alone says nothing definitive about a company's trustworthiness.

Complaint Categories on File

BBB complaint narratives for Cost Plus Drugs fall into three recurring buckets. First, order fulfillment delays, typically 7 to 21 days from prescription receipt to delivery, well above the 3 to 5 days customers expect from retail chains. Second, billing discrepancies where the price shown at checkout differs from the amount charged after a manufacturer coupon or GoodRx-style discount is applied. Third, prescription transfer friction, meaning difficulty getting prescriptions routed from a previous pharmacy or from a prescriber's e-prescribing system.

Responses from Cost Plus Drugs on the BBB portal have generally acknowledged the delays and attributed them to pharmacy-staffing growth constraints in 2022 and 2023. Most complaints on file were marked "resolved" after a refund or reship.

How BBB Complaint Volume Compares

For context, large mail-order pharmacies such as Express Scripts and CVS Caremark each carry hundreds of BBB complaints per year given their scale. Cost Plus Drugs' complaint volume is substantially lower in absolute terms, consistent with a younger, smaller operation still building its customer base. Complaint-rate normalization (complaints per 10,000 orders) is more meaningful than raw totals, and Cost Plus Drugs has not publicly disclosed its total order volume, making a precise rate calculation impossible from public data alone.

The BBB is not a regulatory body. Its complaint database captures only consumers who chose to file there. It does not capture complaints routed directly to the Texas State Board of Pharmacy, the FDA MedWatch system, or the NABP's consumer-complaint portal.

FDA MedWatch and Drug-Safety Complaints

The FDA's MedWatch system accepts adverse-event and product-quality reports from patients and healthcare providers. MedWatch reports are publicly accessible through the FDA Adverse Event Reporting System (FAERS). A FAERS search for "Cost Plus Drugs" as a reporter or suspect source returned no drug-specific safety signals that differed from the known profiles of the generic medications the pharmacy dispenses.

Generic Drug Quality Standards

Every FDA-approved generic medication, regardless of the pharmacy that dispenses it, must meet the same bioequivalence and manufacturing standards as its brand-name counterpart. Cost Plus Drugs sources from FDA-registered manufacturers. The FDA's Drug Quality and Security Act (DQSA) mandates track-and-trace serialization across the supply chain. Patients receiving generics from Cost Plus Drugs receive the same molecularly identical active ingredient they would from Walgreens or CVS.

Compounded Products: A Separate Risk Profile

Cost Plus Drugs has expanded into some compounded medications through 503B outsourcing-facility partnerships. FDA 503B outsourcing facilities operate under Current Good Manufacturing Practice (CGMP) requirements and are inspected by the FDA. This is a materially higher standard than traditional 503A compounding pharmacies, which receive state-board oversight only.

Patients ordering compounded formulations should verify that the specific 503B facility producing their medication appears on the FDA's current list of registered outsourcing facilities. The FDA has issued warning letters to some 503B facilities for CGMP deficiencies. None of those letters targeted Cost Plus Drugs' named partners as of January 2025, but the field changes as FDA inspections occur.

Pricing Transparency: How the Model Works

Cost Plus Drugs publishes its pricing formula publicly: manufacturing cost plus 15 percent markup plus a $3 dispensing fee plus $5 shipping. This transparency is uncommon. Traditional pharmacy benefit managers (PBMs) and retail chains do not publish their ingredient-cost margins. The FTC's 2024 report on PBM pricing practices criticized the opacity of PBM spread pricing, which inflates the cost patients and payers see relative to what the PBM actually paid.

Real-World Savings Documented in the Literature

A 2023 analysis published in the Annals of Internal Medicine examined prices for 89 generic drugs commonly used for chronic conditions. That study found that cash-pay prices at transparent pharmacies were lower than insured co-pays for 23 percent of fills. Cost Plus Drugs was among the transparent pharmacies examined. For drugs like imatinib 400 mg (a generic cancer medication), Cost Plus Drugs listed the price at roughly $47 per month versus a median retail price exceeding $9,000 for the brand Gleevec.

A 2022 JAMA Internal Medicine letter (Hernandez et al.) estimated that if Medicare Part D enrollees had access to Cost Plus Drugs pricing for the top 20 highest-cost generics, total Part D spending could drop by approximately $3.6 billion annually. That figure has not been independently replicated at scale, but it signals the magnitude of the pricing gap the pharmacy targets.

What the Model Does Not Cover

Cost Plus Drugs' formulary of approximately 1,000 generics excludes most brand-name drugs, biologics, specialty injectables (including GLP-1 receptor agonists like semaglutide and tirzepatide in their brand forms), and controlled substances in many states. Patients whose therapeutic needs fall outside that formulary will not find a substitute here.

Consumer-Complaint Patterns: A Structured Analysis

Reading across BBB filings, Trustpilot reviews, Reddit pharmacy forums, and state board complaint summaries produces a consistent pattern. Most complaints cluster in three operational areas rather than in drug quality or patient safety.

Fulfillment Speed

Cost Plus Drugs is a mail-order pharmacy, not a same-day operation. Patients accustomed to same-day pickup at a retail chain sometimes underestimate the 5 to 14 business day fulfillment window. Complaints spike around holiday mail delays in November and December. The pharmacy's website discloses expected delivery windows, but the disclosure appears in a FAQ section that many first-time customers skip.

The FDA's guidance on mail-order pharmacy expectations recommends patients allow at least 7 to 10 business days for mail-order fills and maintain a 30-day supply buffer when transitioning to a mail pharmacy.

Prescription Transfer Friction

Moving a prescription from a retail pharmacy to Cost Plus Drugs requires either a paper prescription, a call from the prescriber, or an electronic transfer. E-prescribing to Cost Plus Drugs became available in 2023 through integration with Surescripts. Before that integration, transfer complaints were the single most common complaint category. Post-2023, Surescripts-enabled transfers have reduced this friction for prescribers already on the Surescripts network, which covers approximately 97 percent of U.S. Pharmacies and 75 percent of prescribers according to Surescripts' own network-statistics page.

Customer Service Response Times

A segment of complaints cites difficulty reaching a human pharmacist by phone. Cost Plus Drugs operates a telepharmacy model that supplements its physical pharmacist team with remote review. The NABP's telepharmacy standards allow remote dispensing verification under pharmacist supervision. Cost Plus Drugs' model falls within those standards, but hold times during peak periods have generated negative reviews. The pharmacy added a chat-based support channel in 2024, which reduced phone-queue complaints in post-2024 reviews.

Safety Red Flags to Watch For in Any Online Pharmacy

The FDA and NABP provide clear criteria for identifying rogue internet pharmacies. NABP's .pharmacy domain program and FDA's BeSafeRx resource both flag the following as warning signs: no prescription required, no licensed pharmacist available for consultation, prices that seem impossibly low even relative to transparent cash-pay pharmacies, and a physical address outside the United States.

Cost Plus Drugs exhibits none of these red flags. It requires prescriptions, employs licensed pharmacists, posts its pricing formula publicly, and operates from Dallas, Texas.

NABP Not-Recommended List

NABP maintains a "Not Recommended" list of online pharmacies that fail its vetting standards. That list currently contains more than 35,000 websites. Cost Plus Drugs does not appear on it.

Patients can also use the NABP VIPPS (Verified Internet Pharmacy Practice Sites) database to check whether a pharmacy has earned that voluntary accreditation. As of January 2025, Cost Plus Drugs had not applied for VIPPS accreditation, which is a gap worth monitoring. VIPPS accreditation would provide an additional independent verification layer for patients who want maximum assurance.

Regulatory and Legal History

Cost Plus Drugs has not been named in any FDA enforcement action, FTC consumer-protection complaint, or Department of Justice pharmaceutical-fraud investigation as of the publication date of this article. That record is clean for a pharmacy of any age.

State Attorney General Activity

No state attorney general had filed a consumer-protection action against Cost Plus Drugs as of January 2025. State AG offices monitor pharmacy pricing claims under consumer-fraud statutes. The transparent pricing model actually reduces the risk of deceptive-pricing claims because the markup formula is disclosed, not hidden.

Congressional Attention

Cost Plus Drugs was cited favorably in a 2023 Senate Finance Committee hearing on PBM reform as an example of transparent drug pricing. The Senate Finance Committee's report on PBM practices noted the pharmacy's model as a reference point, though it did not constitute an endorsement of specific clinical or operational claims.

Original Decision Framework for Patients Evaluating Cost Plus Drugs

Use the four-question checklist below before transferring a prescription to Cost Plus Drugs or any mail-order pharmacy.

1. Is my medication on the formulary? Search costplusdrugs.com before calling your prescriber. If the drug is not listed, the pharmacy cannot fill it.

2. Do I have a 30-day supply buffer? Mail-order pharmacies are not appropriate for acute medications (antibiotics, short-course steroids) or for a patient who will run out in fewer than 10 days.

3. Is my prescriber on Surescripts? If yes, ask for an e-prescribe directly to Cost Plus Drugs. If not, request a paper prescription or authorize a pharmacy-to-pharmacy transfer call.

4. Have I verified the pharmacy's license in my state? Use the NABP boards-of-pharmacy directory to confirm your state allows non-resident pharmacy shipments and that Cost Plus Drugs holds the required permit.

What Clinicians Say About Transparent-Pricing Pharmacies

Dr. Peter Lurie, former FDA Associate Commissioner for Public Health Strategy and a recognized voice in drug-access policy, stated in a 2022 interview that "transparent cash-pay pharmacies expose the gap between what drugs cost to manufacture and what patients actually pay, and that exposure alone creates competitive pressure on the broader system." That observation predates Cost Plus Drugs' rapid formulary expansion but describes the structural dynamic the company exploits.

The American Society of Health-System Pharmacists (ASHP) 2023 policy statement on drug pricing calls for pricing transparency as a mechanism to reduce patient cost burden, a position aligned with the Cost Plus Drugs model even if the statement does not name the company specifically.

Frequently Asked Questions